Avery Laboratories, Inc. was founded by Roger Avery in the late 1960’s. It was renamed Avery Biomedical Devices, Inc. in 2005 and have:
The Avery model S-242 was the first commercially distributed Diaphragm Pacemaker.
The current Avery model:
The Spirit Diaphragm Pacemaker
Based on his pioneering research in cardiac pacemakers, William W.L. Glenn and his colleagues at the Yale University School of Medicine set out to create the first practical application of phrenic nerve pacing. Although first mentioned in 19664, the seminal work on the topic was an article titled “Radio-Frequency Electrophrenic Respiration. Long-term application to a patient with primary hypoventilation” which appeared in the March 1968 issue of the Journal of the American Medical Association5.
In collaboration with Roger E. Avery, Glenn’s prototypes were brought into commercial distribution by Avery Laboratories, Inc. in 1971. The Medical Device Amendment of 1976 mandated the classification and regulation of medical devices and in 1986, under FDA regulations the Medical Device Amendments were enacted into law. In January of 1987 Avery became one of the first to obtain PMA approval under this regulation.
Furthermore, in 1995 Avery breathing pacemaker system was one of the first products to obtain premarket approval as a Class III device under the requirements of the Active Implantable Medical Device Directive (90/385/EEC) for distribution within the European Union.
In July 2015, Dr. Dilys Gore, Tony Martins and Linda Towler, three long-time employees of Avery Biomedical Devices (ABD), purchased majority ownership of ABD from the Estate of Claire Dobelle.
Newly focused, yet with the benefit of wisdom, we will always hold the highest quality standard for the Company to ensure the Avery Diaphragm Pacing System improves the quality of life of those we serve. This is our personal commitment to you. Our vision for the future is to expand our research & development department enabling us to collaborate with our clinicians, universities and of course, our users to develop innovative medical devices and technologies. We hope you will be pleased with our commitment to you.
Since the commercial introduction of Diaphragm Pacing Systems, there have been substantial advancements in the state of the art surgical techniques. Concurrently, the introduction of cervical and thoracoscopic minimally invasive approaches advanced the implantation of Diaphragm Pacemakers.
Learn More4Glenn WW, Anagnostopoulos CE. “Electronic pacemakers of the heart, gastrointestinal tract, phrenic nerve, bladder, and carotid sinus: current status.” Surgery, 1996 Aug; 60 (2): 480-94.
5Glenn WW, Judson JP. “Radio-frequency electrophrenic respiration. Long-term application to a patient with primary hypoventilation.” Journal of the American Medical Association. March 1968, 203(12), pp. 1033-1037.
Our normal operating hours are from 8 AM to 4 PM Eastern Time (EST)
Monday through Friday.
© 2012 – 2023 Avery Biomedical Devices, Inc. All Rights Reserved